pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
AMGEN · news · pharmadog
← back to AMGEN
News mentioning AMGEN
239
stories
Aug 27, 26
AstraZeneca, Amgen notch another late-stage win for Tezspire, this time in esophagitis
biospace
Aug 27, 26
Myriad catalysts on deck for obesity’s brightest stars as market continues to accelerate
biospace
Aug 26, 26
Vitruvias vanishes amid thyroid tablets recall over potential ‘superpotency’ concerns
biospace
Aug 26, 26
Boston Scientific hit by cyberattack causing ‘disruptions’ to parts of its business
fiercebiotech
Aug 25, 26
Amgen, academic centers weigh new FDA pilot to speed early drug trials
endpoints
Aug 25, 26
After some ‘tough years,’ Frontier’s CEO is ramping up ambitions for precision med platform
fiercebiotech
Aug 24, 26
STAT+: Lady Gaga and her fiancé launch a biotech startup
stat
Aug 20, 26
Chutes & Ladders—Neumora shuffles leadership ahead of IND
fiercebiotech
Aug 20, 26
Scribe’s early-stage IPO standout defies biotech’s derisking trend
biospace
Aug 20, 26
Why pediatric rare oncology outperforms in a volatile biotech market
biospace
Aug 19, 26
Amgen abandoning $500M+ Crohn’s collab won’t derail TScan’s pipeline strategy
fiercebiotech
Aug 19, 26
Amgen cans its TScan partnership; Amylyx reveals $350M offering
endpoints
Aug 18, 26
AstraZeneca scores in lung cancer; Sandoz inks a China deal
biopharma dive
Aug 18, 26
Sandoz inks $322M Henlius deal for rights to as many as 10 biosimilars
biospace
Aug 17, 26
Slate uses Fulcrum to vault onto Nasdaq with $245M financing for migraine trials
fiercebiotech
Aug 17, 26
Baylor Genetics hit by cybersecurity attack targeting patient, staff information
fiercebiotech
Aug 14, 26
Bristol Myers wins ‘milestone’ FDA approval of myeloma drug acquired from Celgene
biopharma dive
Aug 14, 26
Pressure piles on Amgen after EU pulls Tavneos, flags 'serious breaches' in pivotal study
biospace
Aug 13, 26
'Incorrect and misleading' data prompted decision to pull Tavneos in Europe
endpoints
Aug 13, 26
July's biopharma layoffs affect 466 employees, a 94% year-over-year drop
biospace
Aug 12, 26
Pfizer’s former chemistry whiz debuts Khartis Therapeutics with $95M for thyroid eye disease pill
fiercebiotech
Aug 12, 26
7 companies hiring in North Carolina now
biospace
Aug 12, 26
Replimune finally wins approval, Q2 earnings wrap up, psychedelics stay in spotlight
biospace
Aug 11, 26
Amgen lays groundwork for new R&D center in Hyderabad
fiercebiotech
Aug 10, 26
MoonLake’s nanobody boosts all clinical endpoints in phase 3 psoriatic arthritis trial
fiercebiotech
Aug 7, 26
Latigo IPO raises nearly $350M for pain drug development
biopharma dive
Aug 6, 26
Context scraps bispecific T-cell engager program to extend cash runway deeper into 2027
fiercebiotech
Aug 5, 26
STAT+: Moderna launches early trial of Ebola mRNA vaccine
stat
Aug 5, 26
Amgen’s MariTide stands alone after obesity cull while analysts seek more M&A
biospace
Aug 4, 26
Amgen culls early-stage obesity candidate, makes pipeline updates
endpoints
← prev
page 5 of 8
next →